Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 2

Sponsor Class

OTHER 5NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2Gastrointestinal 2Sarcoma 1

Conditions

Lung Neoplasms 6Sarcoma 5Carcinoma, Non-Small-Cell Lung 5Melanoma 4Colorectal Neoplasms 4Neoplasm Metastasis 3Colonic Neoplasms 3Thymoma 2Rectal Neoplasms 2Neoplasms 2Mesothelioma, Malignant 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Carcinoma, Basal Cell 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Tobacco Use Disorder 1Temporomandibular Joint Disorders 1Squamous Cell Carcinoma of Head and Neck 1Smoldering Multiple Myeloma 1Smoking 1Small Cell Lung Carcinoma 1Neoplasms, Germ Cell and Embryonal 1Neoplasm, Residual 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Mesothelioma 1Liver Neoplasms 1Gastrointestinal Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

Fluorouracil 11Cisplatin 10Radiotherapy 9Paclitaxel 7Trastuzumab 5Erlotinib Hydrochloride 5Specimen Handling 4Taxes 3Radiation 3Nivolumab 3Magnetic Resonance Spectroscopy 3Leucovorin 3Irinotecan 3Carboplatin 3trastuzumab biosimilar HLX02 2entinostat 2alvocidib 2Psychiatric Rehabilitation 2Plicamycin 2PF-05280014 2Oxaliplatin 2Ontruzant 2Ogivri 2Neoadjuvant Therapy 2Microarray Analysis 2Epirubicin 2Decitabine 2Celecoxib 2CT-P6 2Brachytherapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Esophageal Neoplasms × Celecoxib × Clear all
NCT01143545 2020-03-03

Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
10 enrolled
GastrointestinalOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Esophageal Neoplasms, Lung Neoplasms, Sarcoma, Thymoma

NCT01258868 2019-12-03

Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
44 enrolled
GastrointestinalOther solid neoplasmThoracic

Esophageal Neoplasms, Lung Neoplasms, Mesothelioma, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡